Skip to main content
. 2017 Jun 23;31(7):1008–1019. doi: 10.1038/eye.2017.80

Table 3. Comparison of our outcomes with previous results of augmented trabeculectomy and deep sclerectomy in uveitis.

Reference Procedure Mean follow up (months) Eyes (n) Main IOP outcome Success at 1 year (% eyes) Success at 5 years (% eyes) Long-term hypotony (% eyes)
Noble et al6 MMC trab 52 21 <30% pre-op 90.0 NA 9.5
Kaburaki et al7 MMC trab 65 53 <21 mm Hg NA 79.1 (Q) 28.3
Prata et al34 MMC trab 10 24 <21 mm Hg 91.7 NA 8.3
Ceballos et al11 MMC trab 29 44 <21 mm Hg 78.0 NA 7.0
Towler et al35 5-FU trab 43 50 <21 mm Hg 88.0 (Q) 67.0 (Q) 0
Chawla et al12 5-FU trab 61 31 <21 mm Hg 90.0 (Q) 76.5 (Q) 0
Al Obeidan26 DS only 21 13 ‘IOP control’ at last visit 84.6 (U) 92.3 (Q) NA 7.7
Al Obeidan29 DS MMC 33 33 <23 mm Hg 72.7(U)a 93.9 (Q)a NA 3.0
        <18 mm Hg 69.7 (U) 81.8 (Q) NA  
Auer et al27 DS only 12 14 <21 mm Hg 45.4 (U) 91.0 (Q) NA 7.1
Anand et al28 DS MMC >46 26 <21 mm Hg 89.0 (U/Q)b NA NA
This study DS MMC >68 43 <22 mm Hg 88.0 (U) 93.0 (Q) 60.0 (U) 74.0 (Q) 4.7
        <19 mm Hg 81.0 (U) 86.0 (Q) 51.0 (U) 60.0 (Q) 4.7

Abbreviations: MMC, mitomycin C; trab, trabeculectomy; 5-FU, 5-fluorouracil; DS, deep sclerectomy; IOP, intraocular pressure; Q, qualified success; UQ, unqualified success.

a

Outcome data reported at<3 years.

b

Outcome data reported at 3 years.